Pila Pharma’s capital raise oversubscribed by 293 percent to fund obesity studies
Biotech company Pila Pharma has recently completed a strongly oversubscribed share issue on Nasdaq First North in Stockholm. The raised capital of nearly SEK 30 million will finance the first steps of development of a next-generation, tablet-based treatment for obesity with global potential.
